Skip to main content
OpenTrials
Completed

NCT Number: NCT00523146

Treatment of Primary Menstrual Pain With Kanion Capsule

The objectives of this clinical trial are:

* To further study the safety of Kanion Capsule (GF) in primary dysmenorrhea subjects; * To further evaluate the efficacy of GF in treatment of primary dysmenorrhea.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2

Primary location

Mount Vernon Clinical Research, LLC

Sandy Springs, Georgia, 30328, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • primary dysmenorrhea

Exclusion criteria

  • secondary dysmenorrhea

Treatment and study plan

Kanion Capsule

Drug

Primary outcomes

  1. pain reduction

    Time frame: 6 months

Secondary outcomes

  1. accompanying symptoms improvement

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Lianyungang Kanion Group, Ltd.

Industry

Registry information

Official study title

Treatment of Primary Dysmenorrhea With Kanion Capsule (GF) A Randomized, Double-blind, Placebo-controlled, Repeated-Dose and Multi-Center Clinical Phase II Trial

Important dates

Study start
2007
Primary completion
2008
Study completion
2009
First posted
Aug 31, 2007
Registry last updated
Feb 3, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.